Dr. Vicente E. Torres, MD

Dr. Torres practices at Mayo Clinic Hospital, Saint Marys Campus in Rochester, Minnesota, part of Mayo Clinic.

Dr. Torres' NPI, 1396722781, was assigned on December 27, 2005. Dr. Torres holds Minnesota license 22750.

Dr. Torres' primary practice is Mayo Clinic Hospital, Saint Marys Campus, at 1216 Second Street Southwest, Rochester, MN 55902 in Olmsted County. The practice phone is (507) 255-5123.

Dr. Torres' primary practice is Mayo Clinic Hospital, Saint Marys Campus in Rochester, Minnesota, part of Mayo Clinic. The medical group on file is Mayo Clinic. Dmand AI also links Dr. Torres to 1 more hospice, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Torres practices, 2 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Torres' primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Torres is licensed in Minnesota.

CMS data shows 40 Medicare services from Dr. Torres across 2 procedure codes in 2024, all of them office visits, for 33 Medicare patients. Medicare paid $2,951 for them. Every service was in an office.

CMS counts 33 Medicare patients who saw Dr. Torres in 2024. The largest group is 65 to 74, with 21 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. Their average risk score is 1.43, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Torres' median patient age at 57, with 68% women.

In 2024, Dr. Torres wrote 307 Medicare Part D claims for 45 patients. 92% of them were for generic drugs. CMS names the drug for 158 of them, across 9 drugs with 11 or more claims each, at $263,942 in total drug cost. In 2023, CMS named 183 claims across 11 drugs.

Dr. Torres accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Torres as offering telehealth.

Dmand AI links 248 papers to Dr. Torres, published from 2004 to 2025. 2020 was the busiest year, with 23. The most frequent topics are Polycystic Kidney, Autosomal Dominant, Kidney and Disease Progression. Dr. Torres has published most often in J Am Soc Nephrol. Dr. Torres' most frequent co-authors are Ronald D. Perrone, MD, Fouad Chebib, MD and Theodore Irving Steinman, MD.

Dmand AI links Dr. Torres to 5 clinical trials, 5 of them phase 3 studies. Conditions studied include Polycystic Kidney, Autosomal Dominant and Polycystic Kidney Diseases. Otsuka Pharmaceutical Development & Commercialization, Inc. sponsors the most, 3. Open Payments lists research payments to Dr. Torres that name 3 trials.

CMS Open Payments shows 50 general payments to Dr. Torres from 8 drug and device companies from 2016 to 2023. Grants make up the largest share, 31% of the total. Kadmon Corporation LLC paid the most, $20,000. It also lists 16 research payments totaling $21,476 from 2016 to 2020, naming 3 clinical trials.